Mental disorder or conscious disturbance in epidermal growth factor receptor-tyrosine kinase inhibitor treatment of advanced lung adenocarcinoma

Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are currently recommended by international guidelines as first-line treatment in patients with advanced EGFR-mutant non-small-cell lung cancer. With the availability of drugs, more and more patients choose EGFR-TKI treatment. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jing, Zhou, Rui, Xiao, Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105942/
https://www.ncbi.nlm.nih.gov/pubmed/32256269
http://dx.doi.org/10.17179/excli2019-1964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105942/
https://www.ncbi.nlm.nih.gov/pubmed/32256269
http://dx.doi.org/10.17179/excli2019-1964

Ejemplares similares